Search Results - "ZIYI LIM"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    IL‐17‐producing CD4+ T cells, pro‐inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome by Kordasti, Shahram Y., Afzali, Behdad, Lim, Ziyi, Ingram, Wendy, Hayden, Janet, Barber, Linda, Matthews, Katie, Chelliah, Rajani, Guinn, Barbara, Lombardi, Giovanna, Farzaneh, Farzin, Mufti, Ghulam J.

    Published in British journal of haematology (01-04-2009)
    “…Summary Immunological responses are increasingly recognised as being important in the initiation and progression of myelodysplastic syndrome (MDS). Indeed,…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Hepatitis B virus infection: pathogenesis, reactivation and management in hematopoietic stem cell transplant recipients by Moses, Samuel E, Lim, ZiYi, Zuckerman, Mark A

    Published in Expert review of anti-infective therapy (01-10-2011)
    “…Hepatitis B virus (HBV) is a partially double stranded DNA virus that can integrate into host cell chromosomes as covalently closed circular DNA forms. HBV…”
    Get more information
    Journal Article
  11. 11
  12. 12

    Allogeneic Stem Cell Transplantation for Accelerated/Blastic Phase Philadelphia-Chromosome Negative MPN by Khan, Anjum Bashir, McLornan, Donal, Jethava, Yogesh, Raj, Kavita, Potter, Victoria T, de Lavallade, Hugues, Kazmi, Majid A, Lim, ZiYi, Marsh, Judith C.W., Atwal, Sangeeta, Noriega, Victor, Harrison, Claire N, Pagliuca, Antonio, Mufti, Ghulam J.

    Published in Blood (16-11-2012)
    “…Abstract 4532 Myeloproliferative Neoplasm (MPN)-Leukaemic Transformation (LT) uniformly carries a dismal prognosis. Effective therapy for such patients are…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Pre-Emptive Donor Lymphocyte Infusions (DLI) Lead to High Cure Rates in T-Cell Depleted Allogeneic Haemopoietic Stem Cell Transplants for MDS/AML by Krishnamurthy, Pramila, Potter, Victoria T, Lim, ZiYi, Kulasekararaj, Austin G, Ho, Aloysius Y, Marsh, Judith C.W., Ireland, Robin M., Devereux, Stephen, Pagliuca, Antonio, Mufti, Ghulam J.

    Published in Blood (18-11-2011)
    “…Abstract 660 Relapse is a major cause of treatment failure following allogeneic haemopoietic stem cell transplants (HSCT). Donor lymphocyte infusions may be…”
    Get full text
    Journal Article
  16. 16

    Long-Term Outcomes of Reduced Intensity Conditioning Haematopoietic Stem Cell Transplantation (RIC-HSCT) for AML with Myelodysplasia-Related Changes by Potter, Victoria T, Krishnamurthy, Pramila, Lim, ZiYi, Tindell, Victoria J, Devereux, Stephen, Marcus, Robert E., Ireland, Robin M., Marsh, Judith C.W., Pagliuca, Antonio, Mufti, Ghulam J.

    Published in Blood (18-11-2011)
    “…Abstract 3079 Patients with acute myeloid leukaemia secondary to myelodysplastic syndromes (sAML) are often considered to have inferior outcomes to patients…”
    Get full text
    Journal Article
  17. 17

    Telomere Length In MDS Patients Bone Marrow Is Highly Correlated with Complex Cytogenetics, IPSS Risk Groups and Transfusion Dependency by Jiang, Jie, Kulasekararaj, Austin G, Krishnamurthy, Pramila, Smith, Alexander E, Mian, Syed A, Gandhi, Shreyans, Hayden, Janet, Gaken, Joop, Elebute, Modupe, Ireland, Robin M., Lim, ZiYi, Marsh, Judith C.W., Mufti, Ghulam J.

    Published in Blood (18-11-2011)
    “…Abstract 3826 Myelodysplastic syndromes (MDS) are hematopoietic stem cell disorders characterized by ineffective haematopoiesis. Age, gender, mutagen exposure…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20